The expression of IGF2BP3 is related to disease recurrence and cancer-specific mortality in urothelial carcinoma, which could improve risk stratification of urothelial carcinoma patients undergoing radical nephroureterectomy [44]. This evidence concerns the gene IGF2BP3 and cancer.